Open your phone, scroll for thirty seconds, and you’ll be offered a new serum, a new device, a new injectable or a new “protocol” promising to fix something you didn’t know was a problem until the ad told you. The numbers back this up: Americans underwent more than 28 million minimally invasive cosmetic procedures in 2024 alone. Neuromodulator injections, including Botox, Dysport and similar products, remained the most popular minimally invasive cosmetic procedure in 2024, with nearly 9.9 million treatments —up 4% from the year before. Dermatology and skincare have become one of the most crowded, fastest-moving corners of consumer health — and most people have no reliable way to sort what’s actually worth doing from what’s just well-marketed.

Wanting healthier, good-looking skill is not the problem. The problem is that the market has made it increasingly difficult to know what actually works, what’s worth paying for and when more treatment becomes too much.

The trend is even taking patients abroad. U.S. patients traveling to South Korea for medical care reached a record 173,363 in 2025, up 70.4% from the previous year, according to South Korea’s Ministry of Health and Welfare. South Korea’s competitive market has made it possible to get the same procedures for a fraction of U.S. prices — 50 units of facial Botox runs about $500 here, compared to roughly $20 there.Dermatology was the largest specialty among American patients, accounting for 44.3% of their visits. Across all foreign patients, dermatology accounted for nearly 1.3 million visits, or 62.9% of the total.

A Filter, Not a Shopping List

Rather than ranking products, it’s more useful to think in three buckets:

● Evidence-based — backed by clinical research, the kind of thing a dermatologist would recommend without hesitation.

● Trend-driven, low-risk — not proven, but largely harmless if you’re not overdoing it.

● Actively risky — unregulated, easy to overuse, or prone to backfire.

Almost everything on the market fits somewhere in this framework, and running a new product or procedure through it — rather than through “does it look good on Instagram” — is a faster way to decide whether it’s worth your time, or your money.

What a Dermatologist Actually Recommends

Dr. Hysem Eldik, M.D., a board-certified dermatologist in New York City, puts the basics first. “A retinoid is considered the lighthouse in navigating the oversaturated market of skin care and anti-aging,” he says. “It’s evidence-based and works on fine lines, wrinkles, texture, pores and sun spots. It is appropriate for almost anyone 20-years-old and up and can include both over-the-counter products and prescription tretinoin.” His other workhorse: a broad-spectrum sunscreen, preferably one made in Europe that contains newer filters such as bemotrizinol. “Although they have recently been approved in the U.S., they have not made it to the shelves,” he notes.

The gap between what’s popular and what’s proven is often wider than people expect. “Red light masks overpromise and under-deliver,” Eldik says. “It has swept the market out of virality and popularity but lacks the technology and science to yield a meaningful change towards anti-aging. They are also ludicrously overpriced.” He is equally skeptical of collagen gummies and similar supplements. “We don’t have the digestive mechanisms to turn these into the building blocks of collagen or elastin production so it essentially goes right through us. If you put these resources towards a certain laser procedure, it would be exponentially more effective.”

Here’s the part that doesn’t get mentioned enough: dermatology and aesthetics are largely cash-pay. That changes the incentive structure. In insurance-covered medicine, there’s at least some distance between a provider recommending a treatment and a patient paying for it. In cash-pay aesthetics, the person recommending the treatment may also be the person selling it.

That doesn’t mean providers are acting in bad faith — most aren’t. But it does mean the burden shifts to the patient to ask good questions: is this the most effective option, or the most profitable one to offer? Is a “membership” or subscription plan solving a real problem, or creating a reason to keep coming back? The money at stake is real: McKinsey’s 2026 State of Beauty report projects that the global beauty market will grow 5% annually through 2030, reaching $590 billion . And that kind of growth doesn’t happen without a lot of very persuasive marketing aimed squarely at consumers.

Eldik’s advice for patients trying to separate medical judgment from a sales pitch is straightforward: “Consulting with a board-certified dermatologist before embarking on a skin care journey is crucial. They will help navigate what is necessary, elective but beneficial and useless.” He adds that price can be a clue when businesses are marketing everyday products. “Price point can be a helpful tool in differentiating business-focused models like those that market inflated everyday products such as moisturizers, sunscreens and cleansers.”

For Readers With More to Spend

Having more disposable income doesn’t protect you from over-treatment — if anything, it removes the one thing that naturally limits most people’s exposure to it: cost.

For patients with the means to pursue virtually every treatment available, Eldik’s answer to “when is enough enough?” depends on the procedure. “Certain mild to moderate strength lasers for example, I take a ‘more the merrier’ approach that can help with skin tightening, resurfacing, etc. Botox every 3-4 months is also appropriate in helping to prevent etched lines and wrinkles when done strategically and artfully.” But he sees filler differently. “I think the procedure that gets flagged here is filler. An advanced dermatologist would not even encroach on the territory of too much filler, waiting only for when it needs replenishing after it starts to dissolve over many months and even years.”

None of this is an argument for doing less. It’s an argument for doing the right things, in the right order, for the right reasons. Evidence over trend. An individual assessment over whatever happens to be trending in your feed. And when in doubt, ask your provider why a treatment is appropriate for you — not simply whether they offer it.